Establishment Labs Holdings Inc.
NASDAQ:ESTAMedical - Devices
+$2.65 today
- Market cap
- $2.11B
- Beta
- 1.11
- P/E (TTM)
- -57.6
- EPS (TTM)
- -$1.48
Volume 0.38M
Average 0.50M
ESTA EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Establishment Labs Holdings Inc.NASDAQ: ESTA
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA remains negative
Q3 FY2026 EBITDA was -$3.29M, compared with -$1.98M a year earlier. Trailing-twelve-month EBITDA was -$10.54M.
Context
- EBITDA amounted to 10.6% of revenue in FY2025, down 23.3 pp from a year earlier.
- EBITDA grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 7 analysts of -$5.73M (+74.3%) for the fiscal year ending Dec 2026, a step up from the +60.4% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- -$3.29M-61.2% QoQ
- Last fiscal yearDec 2025
- -$22.29M+60.4% YoY
- LTMSep 2026
- -$10.54M+78.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -66.3% | +330.4% | +396.7 pp |
| 1 year | +60.4% | +74.3% | +14.0 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (22.29M) USD
- Year-over-year change
- +60.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (22.29M) | +60.4% |
| FY2024 | 2024-12-31 | (56.22M) | +3.6% |
| FY2023 | 2023-12-31 | (58.31M) | -2.8% |
| FY2022 | 2022-12-31 | (56.73M) | -113.8% |
| FY2021 | 2021-12-31 | (26.53M) | — |
EBITDA vs competitors
How ESTA compares with its peers on the latest reported figures
- ESTA's LTM Sep 2026 EBITDA of -$10.54M is the 2nd highest of the 4 companies compared; the peer median is -$33.12M.
- Its year-over-year change of +78.0% is the highest of 4, against a peer median of -26.8%.
- EBITDA amounts to 4.0% of revenue for ESTA, versus a peer median of 27.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $102.9M | -26.8% | -18.1% | 27.5% | |
| LTM Sep 2026 | -$10.54M | +78.0% | — | 4.0% | |
| LTM Jun 2026 | -$33.12M | +4.6% | — | 41.4% | |
| LTM Mar 2026 | -$289.3M | -260.5% | — | 17.6% | |
| Peer median (excluding ESTA) | -$33.12M | -26.8% | -18.1% | 27.5% | |
Competitors are the stored peer set for ESTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 126.68M | 161.7M | 165.15M | 166.03M | 211.08M |
| Cost of Revenue | 41.28M | 55.11M | 58.17M | 56.5M | 64.77M |
| Gross Profit | 85.4M | 106.6M | 106.98M | 109.53M | 146.31M |
| Gross Margin | 67.4% | 65.9% | 64.8% | 66.0% | 69.3% |
| Research & Development | 18.32M | 20.27M | 26.43M | 19.71M | 20.25M |
| Selling, General & Admin | 92.23M | 125.98M | 145.58M | 139.81M | 165.07M |
| Operating Expenses | 110.54M | 146.25M | 172M | 159.51M | 185.32M |
| Depreciation & Amortization | 4.12M | 4.34M | 4.88M | 7.58M | 10.47M |
| EBITDA | (26.53M) | (56.73M) | (58.31M) | (56.22M) | (22.29M) |
| EBITDA Margin | -20.9% | -35.1% | -35.3% | -33.9% | -10.6% |
| Operating Income | (25.14M) | (39.66M) | (65.03M) | (49.99M) | (39.01M) |
| Operating Margin | -19.8% | -24.5% | -39.4% | -30.1% | -18.5% |
| Interest Income | 23K | 87K | 1.02M | 1.48M | 423K |
| Interest Expense | 9.06M | 11.76M | 15.39M | 20.83M | 25.26M |
| Other Income / Expenses | (14.57M) | (33.17M) | (13.56M) | (34.64M) | (19.01M) |
| Income Before Tax | (39.71M) | (72.82M) | (78.58M) | (84.63M) | (58.02M) |
| Pre-Tax Margin | -31.3% | -45.0% | -47.6% | -51.0% | -27.5% |
| Income Tax Expense | 1.43M | 2.39M | (81K) | (32K) | (6.96M) |
| Net Income | (41.14M) | (75.21M) | (78.5M) | (84.6M) | (51.06M) |
| Net Margin | -32.5% | -46.5% | -47.5% | -51.0% | -24.2% |
| EPS (Basic) | (1.72) | (3.08) | (3.07) | (3.00) | (1.72) |
| EPS (Diluted) | (1.72) | (3.08) | (3.07) | (3.00) | (1.72) |
| Weighted Avg Shares | 23.97M | 24.46M | 25.6M | 28.16M | 29.62M |
| Weighted Avg Shares (Diluted) | 23.97M | 24.46M | 25.6M | 28.16M | 29.62M |
Establishment Labs Holdings Inc.
NASDAQ:ESTA
Intrinsic Alpha fair value
Locked
Current Price
$70.80
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.